Trading · Founded 1969 · www.uelonline.com · BSE 500429 · NSE UNIENTER · ISIN INE037A01022
No Notes Added Yet
Business
Uniphos Enterprises Ltd. is an India-based company primarily engaged in trading activities. While the specific nature of goods traded can vary, historical information indicates a focus on trading of various chemicals, including intermediates, and agricultural products. The company acts as an intermediary, procuring goods from manufacturers/suppliers and distributing them to end-users or other businesses, thereby earning a margin on the traded volume. Its core business model involves managing logistics, supply chain, and financing to facilitate transactions.
Revenue Mix
Uniphos Enterprises Ltd. primarily operates as a single business segment, "Trading." Publicly available financial reports generally do not break down revenue by distinct product categories within its trading operations, indicating a largely unified trading business without significant, separately reported segments.
Industry
The trading industry in India is highly fragmented and competitive, comprising a wide range of players from small local traders to large multinational trading houses. Uniphos Enterprises Ltd. operates within this general trading landscape, likely focusing on specific niches within chemicals and agri-products where it has established supplier relationships and distribution networks. Its positioning is that of an established, mid-sized player in specific commodity trading segments rather than a broad-line global trading giant.
MOAT
Uniphos Enterprises Ltd. generally operates in a low-moat business. Its potential competitive advantages are primarily operational:
Established Relationships: Long-standing relationships with suppliers and customers can provide a degree of stability and preferential terms.
Logistics & Supply Chain Expertise: Efficient management of procurement, warehousing, and distribution in specific product categories.
Financing Capabilities: Ability to provide credit terms to buyers or manage working capital efficiently for large trade volumes.
However, these advantages are typically not strong enough to create a durable, wide moat as they can often be replicated by competitors.
Growth Drivers
Economic Growth: Overall economic growth in India drives demand for chemicals and agricultural products, which are key items for the company's trading.
Expansion into New Products/Geographies: Strategic initiatives to add new product lines or expand trading operations into new regions could provide growth avenues.
Supply Chain Optimization: Improving efficiency in logistics and inventory management could enhance profitability per unit traded.
Commodity Price Volatility: While a risk, strategic hedging and timely trading during price fluctuations can also be a source of profit.
Risks
Commodity Price Volatility: Fluctuations in the prices of traded goods can significantly impact margins and inventory valuations.
Foreign Exchange Risk: If the company engages in international trade, currency fluctuations can affect profitability.
Credit Risk: Risk of default by counterparties to whom goods are sold on credit.
Supply Chain Disruptions: Issues with sourcing, logistics, or transportation can hinder operations.
Intense Competition: The fragmented nature of the trading industry means constant pressure on margins.
Regulatory Changes: Changes in import/export policies, tariffs, or other trade regulations can impact the business.
Management & Ownership
Uniphos Enterprises Ltd. is part of the broader UPL Group, with the Shroff family (promoters of UPL Ltd.) being the key promoters. Promoters hold a significant stake, which is common in Indian businesses and can align management interests with shareholders. While specific details on the day-to-day management quality would require deeper analysis, the association with the UPL Group suggests a lineage of business acumen in the chemical and agri-products space.
Outlook
Uniphos Enterprises Ltd. operates in a fundamental but competitive trading sector. The company's outlook is closely tied to the broader economic environment and the performance of the specific chemical and agricultural markets it serves. The bull case relies on sustained economic growth in India, effective management of commodity price risks, and leveraging its established relationships and supply chain expertise to capture market share and optimize margins. The bear case involves heightened competition leading to margin erosion, adverse movements in commodity prices, significant supply chain disruptions, or credit defaults from counterparties. While the company's established presence provides a base, significant growth would likely require strategic expansion or diversification within its trading framework.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 51 | 3 | 30 | 5 | 73 | 6 | 0 | 0 | 26 | 0 |
| Other Income | 1 | 1 | 5 | 0 | 0 | 0 | 24 | 0 | 0 | 0 |
| Total Income | 51 | 4 | 35 | 6 | 73 | 6 | 24 | 0 | 27 | 0 |
| Total Expenditure | 52 | 4 | 31 | 6 | 74 | 7 | 1 | 1 | 27 | 1 |
| Operating Profit | -0 | 0 | 4 | -1 | -1 | -1 | 23 | -1 | -0 | -1 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | 4 | -2 | -2 | -1 | 23 | -1 | -1 | -1 |
| Provision for Tax | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -1 | -0 | 4 | -2 | -2 | -1 | 23 | -1 | -1 | -1 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | -1 | -0 | 4 | -2 | -2 | -1 | 23 | -1 | -1 | -1 |
| Adjusted Earnings Per Share | -0.1 | -0 | 0.6 | -0.3 | -0.2 | -0.1 | 3.3 | -0.1 | -0.1 | -0.2 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 32 | 26 |
| Other Income | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 | 24 |
| Total Income | 14 | 13 | 20 | 24 | 24 | 27 | 58 | 45 | 94 | 118 | 57 | 51 |
| Total Expenditure | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 54 | 115 | 36 | 30 |
| Operating Profit | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 40 | 2 | 22 | 21 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 21 | 20 |
| Provision for Tax | -0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -0 | 0 | 0 |
| Profit After Tax | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 21 | 20 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 21 | 20 |
| Adjusted Earnings Per Share | 1.7 | 1.6 | 2.5 | 3 | 2.9 | 3.5 | 7.9 | 5.6 | 5.6 | 0 | 3 | 2.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -71% | 217% | 100% | 0% |
| Operating Profit CAGR | 1000% | -18% | -1% | 6% |
| PAT CAGR | 0% | -19% | -3% | 6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -42% | -18% | -7% | 2% |
| ROE Average | 1% | 1% | 1% | 2% |
| ROCE Average | 1% | 1% | 1% | 2% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 283 | 2067 | 2090 | 2698 | 1518 | 2715 | 3181 | 2998 | 2075 | 2742 | 2447 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 57 | 120 | 97 | -21 | 98 | 144 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 2 | 28 |
| Total Liabilities | 284 | 2067 | 2090 | 2698 | 1519 | 2772 | 3302 | 3095 | 2056 | 2842 | 2619 |
| Fixed Assets | 174 | 175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 107 | 1878 | 2059 | 2659 | 1459 | 2711 | 3242 | 3042 | 2008 | 2825 | 2572 |
| Total Current Assets | 3 | 14 | 31 | 38 | 59 | 61 | 60 | 53 | 48 | 16 | 47 |
| Total Assets | 284 | 2067 | 2090 | 2698 | 1519 | 2772 | 3302 | 3095 | 2056 | 2842 | 2619 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 2 | 1 | 6 | 1 | 43 | 4 | 2 | 1 | 3 | 12 |
| Cash Flow from Operating Activities | -2 | -2 | -3 | -3 | -2 | -5 | 1 | -1 | -3 | -3 | -3 |
| Cash Flow from Investing Activities | 14 | -0 | 9 | -2 | 44 | -34 | 20 | 41 | 50 | 53 | 10 |
| Cash Flow from Financing Activities | -11 | 0 | 0 | 0 | 0 | 0 | -24 | -39 | -45 | -41 | -3 |
| Net Cash Inflow / Outflow | 1 | -2 | 5 | -5 | 42 | -38 | -3 | -0 | 1 | 9 | 3 |
| Closing Cash & Cash Equivalent | 2 | 1 | 6 | 1 | 43 | 4 | 2 | 1 | 3 | 12 | 15 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.7 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | 2.98 |
| CEPS(Rs) | 1.7 | 1.63 | 2.55 | 2.99 | 2.89 | 3.52 | 7.86 | 5.73 | 5.67 | 0.15 | 3.08 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 3.4 | 5.65 | 6.5 | 5.7 | 0.5 | 3.5 |
| Book NAV/Share(Rs) | 19.91 | 276.32 | 279.65 | 367.04 | 197.4 | 369.5 | 436.48 | 410.17 | 277.58 | 373.37 | 330.97 |
| Core EBITDA Margin(%) | 0 | 0 | 0 | 0 | -1302.78 | -368.01 | -255.85 | -194.48 | -6.1 | -3.43 | -11.62 |
| EBIT Margin(%) | 0 | 0 | 0 | 0 | 9006.61 | 2809.85 | 4414.68 | 2691.85 | 76.89 | 1.38 | 65.07 |
| Pre Tax Margin(%) | 0 | 0 | 0 | 0 | 9006.61 | 2809.85 | 4414.68 | 2691.85 | 76.89 | 0.2 | 65.07 |
| PAT Margin (%) | 0 | 0 | 0 | 0 | 8851.15 | 2936.36 | 4469.12 | 2664.95 | 76.24 | 0.25 | 64.72 |
| Cash Profit Margin (%) | 0 | 0 | 0 | 0 | 8867.2 | 2940.51 | 4471.8 | 2705.89 | 77.88 | 0.93 | 66.85 |
| ROA(%) | 4.17 | 0.96 | 0.85 | 0.87 | 0.95 | 1.14 | 1.8 | 1.23 | 1.5 | 0.01 | 0.76 |
| ROE(%) | 8.9 | 1.09 | 0.91 | 0.92 | 1.02 | 1.24 | 1.95 | 1.33 | 1.61 | 0.01 | 0.85 |
| ROCE(%) | 8.85 | 1.09 | 0.93 | 0.94 | 1.04 | 1.19 | 1.92 | 1.35 | 1.63 | 0.07 | 0.85 |
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.49 | 0 | 298.19 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 684.19 | 189.2 | 90.49 | 143.3 | 7.95 | 3.66 | 159.17 |
| PER(x) | 19.84 | 44.15 | 32.48 | 37.36 | 13.62 | 24.15 | 16.86 | 27.29 | 24.13 | 3897.5 | 30.94 |
| Price/Book(x) | 1.69 | 0.26 | 0.3 | 0.3 | 0.2 | 0.23 | 0.3 | 0.38 | 0.48 | 0.42 | 0.28 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 4 | 4.27 | 4.22 | 4.26 | 0.32 | 3.8 |
| EV/Net Sales(x) | 0 | 0 | 0 | 0 | 1016.53 | 703.89 | 747.83 | 705.43 | 17.46 | 9.58 | 19.53 |
| EV/Core EBITDA(x) | 18.91 | 43.9 | 31.42 | 36.49 | 11.27 | 25.01 | 16.93 | 25.81 | 22.23 | 464.68 | 29.06 |
| Net Sales Growth(%) | -100 | 0 | 0 | 0 | 0 | 267.15 | 46.73 | 20.47 | 3340.99 | 120.17 | -71.3 |
| EBIT Growth(%) | 26.04 | -7.51 | 60.16 | 17.44 | -3.58 | 14.54 | 130.53 | -26.54 | -1.71 | -96.04 | 1248.79 |
| PAT Growth(%) | 38.4 | -4.52 | 57.05 | 17.39 | -3.32 | 21.8 | 123.32 | -28.16 | -1.56 | -99.28 | 7341.93 |
| EPS Growth(%) | 38.4 | -4.51 | 57.05 | 17.39 | -3.32 | 21.8 | 123.32 | -28.16 | -1.56 | -99.28 | 7345 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 13.88 | 91.19 | 189.65 | 219.18 | 83.41 | 229.58 | 100.1 | 50.39 | 23.44 | 8.83 | 1.68 |
| Quick Ratio(x) | 13.88 | 91.19 | 189.65 | 219.18 | 83.41 | 229.58 | 100.1 | 50.39 | 23.44 | 8.83 | 1.68 |
| Interest Cover(x) | 31.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 |
| FII | 15.71 | 15.72 | 15.71 | 15.71 | 15.71 | 15.71 | 15.71 | 15.82 | 15.82 | 15.82 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 10.49 | 10.49 | 10.49 | 10.49 | 10.5 | 10.5 | 10.5 | 10.39 | 10.39 | 10.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 |
| FII | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.1 | 1.1 | 1.1 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.72 | 0.72 | 0.72 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -71% | +217% | +100% | — |
| Operating Profit CAGR | +1000% | -18% | -1% | +6% |
| PAT CAGR | — | -19% | -3% | +6% |
| Share Price CAGR | -42% | -18% | -7% | +2% |
| ROE Average | +1% | +1% | +1% | +2% |
| ROCE Average | +1% | +1% | +1% | +2% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 | 73.79 |
| FII | 15.71 | 15.72 | 15.71 | 15.71 | 15.71 | 15.71 | 15.71 | 15.82 | 15.82 | 15.82 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 10.49 | 10.49 | 10.49 | 10.49 | 10.5 | 10.5 | 10.5 | 10.39 | 10.39 | 10.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 |
| FII | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.1 | 1.1 | 1.1 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.72 | 0.72 | 0.72 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.